WYSH Web Application for Hypospadias

(WYSH Trial)

Overseen By Haley Bryte

Age: Any Age

Sex: Male

Trial Phase: Academic

Sponsor: University of Wisconsin, Madison

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

20 Participants Needed

Trial Summary

What is the purpose of this trial?

The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.

Research Team

Vinaya Bhatia, MD

Principal Investigator

UW School of Medicine and Public Health

Eligibility Criteria

This trial is for about 20 males with a history of repaired hypospadias. It aims to see if they find the Care Planning Tool in the WYSH Web Application helpful and easy to use.

Inclusion Criteria

I am a male aged 16-20 and have parental consent.

I am a man between 21 and 65 years old.

I am a male aged 11-15 and have my parents' consent.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete baseline surveys and assessments using the WYSH Web Application

Baseline

1 visit (virtual)

Intervention

Participants use the Care Planning Tool within the WYSH Web Application to address functional and psychosexual health

3 months

Ongoing virtual interaction

Follow-up

Participants are monitored for usability and acceptability of the intervention

3 months

3 visits (virtual)

Treatment Details

Interventions

• WYSH Web Application

Trial Overview The study is testing the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application's Care Planning Tool, focusing on its feasibility and acceptability among participants.

Participant Groups

Group I: Male Participants with Repaired Hypospadias Experimental Treatment 1 Intervention

* 3-5 Males, age 5-10 (with parental consent and child assent) * 3-5 Males, age 11-15 (with parental consent and child assent) * 3-5 Males, age 16-20 (with parent consent, child assent until age 18) * 3-5 Males, age 21-65

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials

1,249

Recruited

3,255,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2,513

Recruited

4,366,000+